Arnaud Marchant

15.1k citations
179 papers · 10.7k · 4 hit papers · h-index 55

Impact in

  • Immunology top 0.2%
    • Immune Response and Inflammation
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
    • Immune responses and vaccinations
    • Immunotherapy and Immune Responses
    • SARS-CoV-2 and COVID-19 Research
    • Tuberculosis Research and Epidemiology

Papers in

    • Immune Response and Inflammation 29
    • Immune Cell Function and Interaction 24
    • Immune responses and vaccinations 23
    • Immunotherapy and Immune Responses 18
    • T-cell and B-cell Immunology 14
    • Cytomegalovirus and herpesvirus research 31

Arnaud Marchant

175 papers receiving 10.5k citations

Arnaud Marchant's Hit Papers

Prevalence and 6‐month recovery of olfactory dysfunction: a multicentre study of 1363 COVID‐19 patients 2021 · 147 citations
1470+11+22Years since publication200400600

Peers

Arnaud Marchant
Comparison fields: 5 of 137
  • Immunology 4.9k
  • Infectious Diseases 2.1k
  • Virology 460
  • Epidemiology 3.0k
  • Microbiology 339
Replace Katie L. Flanagan with:
Katie L. Flanagan Australia
Alexis M. Kalergis Chile
Taco W. Kuijpers Netherlands
Donna L. Färber United States
Beatrix Grubeck‐Loebenstein Austria
Christopher L. Karp United States
R. van Furth Netherlands
Moshe Arditi United States
Frank L. van de Veerdonk Netherlands
Christopher B. Wilson United States
Arnaud Marchant relative to Katie L. Flanagan Australia Katie L. Flanagan's profile →
Citations per field
00.5×1.5×2.5×
Katie L. Flanagan · 1×
Citations per year

Countries citing papers authored by Arnaud Marchant

Since Specialization
Citations

This map shows the geographic impact of Arnaud Marchant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnaud Marchant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnaud Marchant more than expected).

Fields of papers citing papers by Arnaud Marchant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnaud Marchant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnaud Marchant. The network helps show where Arnaud Marchant may publish in the future.

Co-authors

The 25 scholars most cited alongside Arnaud Marchant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Arnaud Marchant Line = papers co-authored together Arnaud Marchant links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 179 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.
Hit paper breakdown →
1993678
2
Immunological mechanisms of vaccine-induced protection against COVID-19 in humans
Hit paper breakdown →
2021386
3 2004354
4 1999329
5 1994323
6
Protecting the Newborn and Young Infant from Infectious Diseases: Lessons from Immune Ontogeny
Hit paper breakdown →
2017310
7 1994297
8 1994252
9 2002228
10 1995223
11 1996201
12 1995200
13 2004194
14 2003186
15 2003177
16 2015176
17 2004171
18 2010170
19 2013150
20
Prevalence and 6‐month recovery of olfactory dysfunction: a multicentre study of 1363 COVID‐19 patients
Hit paper breakdown →
2021147

About Arnaud Marchant

Arnaud Marchant is a scholar working on Immunology, Epidemiology, Infectious Diseases, Obstetrics and Gynecology and Health, having authored 179 papers that have together received 10.7k indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (31 papers), Immune Response and Inflammation (29 papers), Immune Cell Function and Interaction (24 papers), Immune responses and vaccinations (23 papers), Immunotherapy and Immune Responses (18 papers), SARS-CoV-2 and COVID-19 Research (18 papers), COVID-19 Impact on Reproduction (14 papers) and T-cell and B-cell Immunology (14 papers). The work is most often cited by research in Immunology (4.9k citations), Infectious Diseases (2.1k citations), Virology (460 citations), Epidemiology (3.0k citations) and Microbiology (339 citations). Arnaud Marchant has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Michel Goldman, Tobias R. Kollmann, Anne Delvaux, Melanie J. Newport, Catherine Gérard, Donat De Groote, Thierry Velu, Manish Sadarangani, Michel Goldman and Tessa Goetghebuer. Their work appears in journals such as Frontiers in Immunology, The Journal of Infectious Diseases, Vaccine, The Journal of Immunology and European Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact